Skip to main content
. 2022 Jan 30;17(11):1311–1330. doi: 10.1080/15592294.2021.2020436

Table 1.

Description of the cohort.

Group Cases (MS) Controls (NNC)
N individuals 8 14
Sex ratio (F/M) 8:0# 4:10
Age (mean ± SD) 63.1 ± 12.6* 76.4 ± 13.4
PMI (mean ± SD)a 15.6 ± 8.6 21.8 ± 7.7
N brain samples
Type lesion (N)
15
NAWM (15)
23
-
Fraction 1 (% ± SD)
Fraction 2 (% ± SD)
Fraction 3 (% ± SD)
36.6 ± 28.2*
39.2 ± 28.5*
23.8 ± 23.8
61.1 ± 24.3
11.0 ± 10.8
27.3 ± 23.6

MS, Multiple Sclerosis, NNC, non-neurological disease controls, N, number, F/M, female/male, PMI, post-mortem interval, NAWM, normal-appearing white matter, aPMI not available for 4 control individuals. Cell fractions were determined by RefFreeEwas cell type deconvolution. # P-value < 0.05 between cases and controls by chi-square (Χ2) test, * P-value < 0.05 between cases and controls generated by two-tailed independent samples T test.